EXTON, Pa.--(BUSINESS WIRE)--Fibrocell Science, Inc. (OTCBB: FCSC), an autologous cellular therapeutic company focused on the development of innovative products for aesthetic, medical and scientific applications, announced today that it has rescheduled its fourth quarter 2011 business update investor conference call to Tuesday, April 3, 2012 at 8:00 AM Eastern Time.
